Close Menu

NEW YORK – CellaVision announced today it has reached a deal to acquire sample preparation firm RAL Diagnostics for SEK 268 million ($27.7 million).

The acquisition is being funded through a combination of cash and cash equivalents, and a SEK120 million loan arranged by Skandinaviska Enskilda Banken.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.